Willis: Predator or Prey?

future-telescope

The shockwaves from the abrupt collapse of the Aon-Willis Towers Watson merger deal at the end of July will reverberate through the insurance world for months to come.

The US$30.55bn deal was originally announced on 9 March 2020, just as Covid started to ravage the UK, Europe and the USA. The fallout from the collapse in the face of the regulatory impasse with the US Department of Justice has the potential to inflict a corporate Long Covid on both firms.

The most vulnerable to this malaise is

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected].

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: